Position in AMGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,944,274,940
-$627,642,058 QoQ
Shares Held
13,653,692
-13.8% QoQ
Ownership
2.53%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#9
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 48%
Shared 0%
None 52%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $63,698,443,803 across 20 Drug Manufacturers - General names. AMGN ranks #5 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
16,226,398 | $19,462,430,163 | |
| 2 | JNJ |
Johnson & Johnson
|
44,808,254 | $11,379,952,259 | |
| 3 | ABBV |
AbbVie Inc.
|
38,901,001 | $9,789,047,884 | |
| 4 | MRK |
Merck & Co., Inc.
|
48,641,158 | $6,250,388,797 | |
| 5 | AMGN |
Amgen Inc
This page
|
13,653,692 | $4,944,274,940 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
24,004,354 | $3,032,710,073 | |
| 7 | PFE |
Pfizer Inc
|
96,345,452 | $2,319,998,477 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
29,009,025 | $1,671,500,010 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,944,274,940 | 13,653,692 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $5,571,916,998 | 15,836,058 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,153,341,450 | 15,744,528 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $4,489,950,149 | 15,910,525 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $4,518,952,693 | 16,184,781 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $5,057,740,388 | 16,234,121 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,794,819,868 | 14,559,622 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $4,734,625,263 | 14,694,222 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $4,487,556,242 | 14,362,478 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $3,972,508,509 | 13,971,963 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $4,157,298,529 | 14,434,062 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $3,560,525,216 | 13,247,973 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $3,019,469,549 | 13,599,989 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,097,010,168 | 12,810,797 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,493,470,496 | 13,301,365 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,654,693,574 | 11,777,700 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,435,389,669 | 14,119,974 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $3,489,007,729 | 14,428,119 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $2,173,429,089 | 9,660,973 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,106,690,582 | 9,906,845 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,447,477,169 | 10,040,932 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $2,478,150,082 | 9,960,010 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $2,240,698,232 | 9,745,556 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $2,177,106,852 | 8,565,891 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,887,964,478 | 8,004,598 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,472,597,264 | 7,263,835 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||